ConductScience.org, home

Gene · 3777

Papers1,851

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

201 to 220 of 1,851

Download this page as JSON
TitleJournalYearPMIDFound bySource
Large-scale genome-wide association studies reveal the genetic causal etiology between air pollutants and autoimmune diseases.J Transl Med202438685026PubTator, text miningPubMed
Correction to 'Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart'.J Physiol202438678577PubTator, text miningPubMed
Response to a Letter to the Editor: Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.J Physiol202438648379PubTator, text miningPubMed
Comment on: 'Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart' by Saint-Martin Willer et al.J Physiol202438607230PubTator, text miningPubMed
Using Mendelian randomization provides genetic insights into potential targets for sepsis treatment.Sci Rep202438605099PubTator, text miningPubMed
Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesis.Heart Rhythm202438574786PubTator, text miningPubMed
Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.Front Immunol202438566994PubTator, text miningPubMed
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.Am J Respir Cell Mol Biol202438546978PubTator, text miningPubMed
Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces.Mol Immunol202438430689PubTator, text miningPubMed
Proteomic Associations of Adverse Outcomes in Human Heart Failure.J Am Heart Assoc202438420755PubTator, text miningPubMed
Up-regulated expression of two-pore domain K+ channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension.Front Cardiovasc Med202438410243PubTator, text miningPubMed
Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use.BMC Pharmacol Toxicol202438303016PubTator, text miningPubMed
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.EBioMedicine202438301482PubTator, text miningPubMed
A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants.J Pharmacol Exp Ther202438296646PubTator, text miningPubMed
A universal metabolite repair enzyme removes a strong inhibitor of the TCA cycle.Nat Commun202438287013PubTator, text miningPubMed
Enhancing Human Cutaneous Wound Healing through Targeted Suppression of Large Conductance Ca2+-Activated K+ Channels.Int J Mol Sci202438255877PubTator, text miningPubMed
Cerebrospinal Fluid C1-Esterase Inhibitor and Tie-1 Levels Affect Cognitive Performance: Evidence from Proteome-Wide Mendelian Randomization.Genes (Basel)202438254961PubTator, text miningPubMed
Potential Causal Association between Plasma Metabolites, Immunophenotypes, and Female Reproductive Disorders: A Two-Sample Mendelian Randomization Analysis.Biomolecules202438254716PubTator, text miningPubMed
SURGE: uncovering context-specific genetic-regulation of gene expression from single-cell RNA sequencing using latent-factor models.Genome Biol202438254214PubTator, text miningPubMed
Integrative analysis identifies gene signatures mediating the effect of DNA methylation on asthma severity and lung function.Clin Epigenetics202438245772PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3777/papers?page=11